top of page

GENESIS PRODUCT

OTHERS

REGENOSS

FDBA FREEZE DRIED BONE ALLOGRAFT

CORTICAL & CANCELLOUS BONE

Osseogenesis refers to bone formation with no indication of cellular origin.When new bone is formed on or about a graft, it may  be either of graft origin (i.e., from cells that survive the transfer and are capable of forming bone) or from cells of host origin. Surface cells on cortical and cancellous grafts that are properly handled can survive and produce new bone. This early bone formed byviable graft cells is often critical in callus formation during the first 4 to 8 weeks after surgery. Cancellous bone, with its large surface area covered by quiescent lining cells or active osteoblasts, obviously has the potential for more graft-origin new bone formation than does cortical bone.

BONE GRAFT FUNCTION

Corticocancellous and cortical allografts provide structural support and are osteoconductive to a limited degree. Corticocancellous grafts may be prepared from the ilium, the distal femur, or the proximal tibia. Cortical bone may be cut longitudinally to yield struts, which are generally used to buttress preexisting bone or constructs. Full-thickness fibulas may also be used as struts. Full-thickness cortical bone grafts, ranging from short ringlike structures to entire diaphyses, are available and are generally used to fill defects and to buttress constructs.

CORTICOCANCELLOUS AND CORTICAL ALLOGRAFT

FEATURE

RegenOss는 Cortical Bone과 Cancellous Bone을 섞어 동결 건조한 동종골(FDBA:Freeze Dried Bone Allograft)로 골손상 부위의 재생을 촉진하는 성장인자(Growth Factor) 및 기타 단백질과 미네랄 성분의 인자들이 보전되어 있어 골유도 (Osteoinduction) 및 골전도 (Osteoconduction)로 뼈가 재생됩니다.

 

1. 뛰어난 골전도(Osteoinduction) 능력

2. 뛰어난 골유도(Osteoconduction) 능력

3. 재수화가 바로 가능한 주사기 포장

4. 막힘방지용 주사기사용(니들부분포함)

5. 뛰어난 생체 적합성

Product

RegenOss

(Cortical & Cancellous Bone)

0.3㏄

Size

Particle size

200~700㎛

0.6㏄

INGREDIENT

Cortical Bone 70% + Cancellous Bone 30%

bottom of page